Vitamin E & D: Vitamins to Improve Liver Health & Fight Fatty Liver Disease

A growing body of research suggests that vitamin E may play a significant role in protecting and even reversing damage in nonalcoholic fatty liver disease (NAFLD), now more commonly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD). The American Association for the Study of Liver Diseases (AASLD) has highlighted recent findings indicating the potential of vitamin E to mitigate fibrosis, a key indicator of liver damage, in patients with this increasingly prevalent condition.

MASLD, characterized by an accumulation of fat in the liver, is becoming a leading cause of morbidity and mortality worldwide, closely linked to cardiovascular disease, malignancies, and cirrhosis. The rising incidence of obesity is a major contributing factor to the growing prevalence of MASLD.

A study involving over 3,700 patients diagnosed with fatty liver disease demonstrated that supplementation with vitamin E, at doses ranging from 400 to 800 International Units (IU) per day, was associated with a significant reduction in liver fibrosis over approximately two years. This improvement was assessed through measurements of liver elasticity, a key indicator of disease progression.

Vitamin E functions as an antioxidant, neutralizing free radicals and limiting the inflammatory processes that damage liver cells. Dr. Chiti Parikh, an internist, explains that the liver is particularly vulnerable to damage caused by oxidative stress, an imbalance of molecules in the body that can lead to cellular harm. Antioxidants like vitamin E help protect against this damage.

While research has primarily focused on MASLD, it’s important to note that there are two main types of steatotic liver disease: metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD). The benefits of vitamin E have been most extensively studied in relation to MASLD.

Vitamin E is naturally found in foods such as nuts, seeds, and olive oil. Its use as a clinical supplement aims to limit the progression of fibrosis and improve overall liver function, based on accumulating evidence.

Beyond vitamin E, vitamin D is also emerging as a potentially important nutrient in liver health. Research suggests a correlation between low vitamin D levels and an increased risk of developing fatty liver disease. Vitamin D is believed to contribute to reducing inflammation and fat accumulation in the liver.

The body obtains vitamin D through sun exposure and consumption of fortified foods, such as dairy products and certain types of fish. Deficiency in this vitamin is associated with metabolic disturbances that can promote fat buildup in the liver.

The AASLD emphasizes that vitamin E supplementation, at 400-800 IU daily, demonstrated measurable reductions in liver fibrosis in the studied patient group. This supports the clinical utility of the supplement in managing fatty liver disease, but always under medical supervision.

It’s crucial to understand that vitamin E is not universally safe. The Mayo Clinic notes that it is not recommended for individuals with serious liver scarring or type 2 diabetes. The recommended daily allowance (RDA) of vitamin E for adults is 15 milligrams (mg), while a typical supplement may contain around 67 mg. A healthcare professional can determine the appropriate dosage for individual needs.

While promising, these findings underscore the importance of a comprehensive approach to managing MASLD. Lifestyle modifications, including weight reduction and a balanced diet, remain the most effective strategies. Nutritional interventions, such as vitamin E and D supplementation, can serve as complementary therapies, but should be implemented under the guidance of a healthcare provider.

Ongoing research continues to explore the potential of vitamins and supplements to support liver health. The results published by the AASLD open avenues for future investigations into the application of these nutrients in the treatment of various liver pathologies. Regular monitoring of patients and periodic assessment of liver markers are essential for tailoring treatment plans and improving patient outcomes.

October 9, 2025, the Mayo Clinic Staff reported that research suggests vitamin E may boost the liver’s natural antioxidants, help reduce liver inflammation and scarring, and help prevent fat buildup in people with MASLD, but more information is needed to confirm these findings.